Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...

Stakeholders responding to recent draft guidance from the US Food and Drug Administration (FDA) on the use of minimal ...

Ethics committees and funding agencies often receive protocols that involve either too many or too few animals to answer the specific research question being investigated. It is evident that a greater ...

A growing body of experimental research suggests that using ChatGPT can boost short-term performance on some tasks, but may ...

Ten years after tailored radiotherapy (RT) for breast cancer, fewer than 3% of patients had locoregional recurrences (LRR), ...

FY25 profit surge, discounted valuation, and ReSPECT Phase III Rezzayo catalyst in Q2 2026. Click for this CRMD update.

A 2026 product overview examining Trimology's RS2 resistant starch formulation, probiotic ingredient research, BioSignal ...

Good morning, everyone, and welcome to Imunon's Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call. During to ...

There is a lack of studies on lifestyle interventions to improve asthma and allergic disease in women, and Sharmilee M.

Immunovant Sciences saw its experimental drug batoclimab fail to hit the primary goal of a late-stage clinical trial in ...

An evolving understanding of the risks and benefits of HRT has led to a reevaluation of the role of HRT for breast cancer survivors.

Phase II Study in Fragile X Syndrome -- IND clearance received from FDA; first patient enrollment targeted by year-end with ...